Table 5 Descriptive features of the 14 submicroscopic malaria cases
From: Prevalence of submicroscopic malaria infection in immigrants living in Spain
Gender | Age (years) | Area of origin | Time of residence in Spain (years) | Travels to endemic area in the year before inclusion | Time from the last travel to endemic area (months) | Reason for consultation | Antimalarial chemoprophylaxis prior last travel to endemic area | Previous malaria | Detected species |
|---|---|---|---|---|---|---|---|---|---|
Male | 31 | Africa (Mali) | 9.5 | Yes | 7.4 | Immigrant screening | No | No | Plasmodium falciparum |
Male | 42 | Africa (Nigeria) | 16.5 | Yes | 4.5 | Headache, myalgia, others (cough and dyspnea) | Unknown | Yes | Plasmodium falciparum |
Male | 46 | Africa (Equatorial Guinea) | 4.3 | Yes | 5.1 | Asthenia | Unknown | Unknown | Plasmodium falciparum |
Female | 44 | Africa (Equatorial Guinea) | 12.9 | No | Unknown | Immigrant screening | – | Yes | Plasmodium falciparum |
Female | 32 | Africa (Equatorial Guinea) | 12.8 | Yes | 3.7 | Asthenia | No | Yes | Plasmodium falciparum |
Female | 50 | Africa (Equatorial Guinea) | 8.9 | Yes | 2 | Asthenia, headache, general discomfort, myalgia | No | Unknown | Plasmodium falciparum |
Male | 31 | Africa (Eritrea) | 0.3 | No | Unknown | Immigrant screening | – | Unknown | Plasmodium vivax |
Male | 18 | Africa (Equatorial Guinea) | 0.4 | No | Unknown | Immigrant screening | – | No | Plasmodium falciparum + Plasmodium malariae + Plasmodium ovale |
Female | 45 | Africa (Equatorial Guinea) | 7.6 | Yes | 6.0 | Immigrant screening and eosinophilia | No | Unknown | Plasmodium falciparum |
Male | 40 | Africa (Nigeria) | 16.4 | Yes | 8.0 | HIV follow-up | Yes | Yes | Plasmodium falciparum |
Male | 42 | Africa (Nigeria) | 14.2 | No | – | Immigrant screening | – | Unknown | Plasmodium falciparum |
Male | 40 | Africa (Guinea Bissau) | – | Unknown | – | HIV follow-up | – | Yes | Plasmodium vivax |
Female | 62 | Africa (Equatorial Guinea) | – | No | – | Others (low back pain) | – | Unknown | Plasmodium falciparum + Plasmodium ovale |
Female | 39 | Africa (Senegal) | 8.7 | No | – | HIV follow-up | – | Yes | Plasmodium falciparum |